Article info

Download PDFPDF

Original article
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

Authors

  1. Correspondence to Dr Karl Yen, Genentech Inc, 1 DNA Drive, South San Francisco, CA 94080-4990, USA; yen.karl{at}gene.com
View Full Text

Citation

Hanania NA, Noonan M, Corren J, et al
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

Publication history

  • Received December 18, 2014
  • Revised April 10, 2015
  • Accepted May 4, 2015
  • First published May 22, 2015.
Online issue publication 
July 14, 2015

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.